<root><title>Glidipion_addresses</title><anchors id="page1"></anchors><p><span>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via</span><span> the national reporting system listed in</span><span style="underline"> Appendix V</span><span>. By reporting side effects you can help provide more information on the safety of this medicine.</span></p><p><span style="bold">5. How to store Glidipion</span></p><p><span>Keep out of the sight and reach of children.</span></p><p><span>Do not use Glidipion after the expiry date which is stated on the carton and the blister pack after the word “EXP”. The expiry date refers to the last day of that month.</span></p><p><span>This medicine does not require any special storage precautions.</span></p><p><span>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.</span></p><p><span style="bold">6. Contents of the pack and other information</span></p><p><span style="bold">What Glidipion contains</span></p><ul><li><p><span>- The active substance is pioglitazone. Each tablet contains 45 mg of pioglitazone (as hydrochloride).</span></p></li><li><p><span>- The other ingredients are lactose monohydrate, hydroxypropylcellulose, carmellose calcium and magnesium stearate.</span></p></li></ul><p><span style="bold">What Glidipion looks like and contents of the pack</span></p><p><span>Glidipion 45 mg tablets are white, round, flat, bevelled, 8 mm in diameter and engraved with ‘TZ45’ on one side.</span></p><p><span>The tablets are supplied in aluminium blister packs of 14, 28, 30, 50, 56, 84, 90, 98 and 100 tablets. The packs with 14, 28, 56, 84 and 98 tablets contain blisters with abbreviations for days of the week printed on the blister (MON, TUE, WED, THU, FRI, SAT, SUN).</span></p><p><span>Not all the pack sizes may be marketed.</span></p><p><span style="bold">Marketing Authorisation Holder and Manufacturer</span></p><p><span style="italic">Marketing Authorisation Holder</span></p><p><span>Actavis Group PTC ehf.</span></p><p><span>Reykjavíkurvegi 76-78</span></p><p><span>220 Hafnarfjörður</span></p><p><span>Iceland</span></p><p><span style="italic">Manufacturer</span></p><p><span>Actavis Ltd.</span></p><p><span>BLB 016 Bulebel Industrial Estate</span></p><p><span>Zejtun ZTN 3000</span></p><p><span>Malta</span></p><p><span>For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:</span></p><p><span style="bold">België/Belgique/Belgien</span></p><p><span style="bold">Lietuva</span></p><p><span>ALL-in-1 bvba</span></p><p><span>UAB “Actavis Baltics”</span></p><anchors id="page2"></anchors><table columns="2" rows="14"><row><cell><p><span>Tél/Tel: +32 3 451 26 88</span></p></cell><cell><p><span>Tel: +370 5 260 9615</span></p></cell></row><row><cell><p><span style="bold">България</span></p><p><span>Актавис ЕАД</span></p><p><span>Teл.: +359 2 9321 680</span></p></cell><cell><p><span style="bold">Luxembourg/Luxemburg</span></p><p><span>ALL-in-1 bvba</span></p><p><span>Belgique/Belgien</span></p><p><span>Tél/Tel: +32 3 451 26 88</span></p></cell></row><row><cell><p><span style="bold">Česká republika</span></p><p><span>Actavis CZ a.s.</span></p><p><span>Tel: +420 251 113 002</span></p></cell><cell><p><span style="bold">Magyarország</span></p><p><span>Actavis Hungary Kft. Tel.: +36 1 501 7001</span></p></cell></row><row><cell><p><span style="bold">Danmark</span></p><p><span>Actavis A/S</span></p><p><span>Tlf: +45 72 22 30 00</span></p></cell><cell><p><span style="bold">Malta</span></p><p><span>Actavis Ltd.</span></p><p><span>Tel: +35621693533</span></p></cell></row><row><cell><p><span style="bold">Deutschland</span></p><p><span>Actavis Deutschland GmbH &amp; Co. KG Telefon: +49 (0)89 558909 0</span></p></cell><cell><p><span style="bold">Nederland</span></p><p><span>Actavis B.V.</span></p><p><span>Tel: +31 35 54 299 33</span></p></cell></row><row><cell><p><span style="bold">Eesti</span></p><p><span>UAB “Actavis Baltics” Eesti Filiaal Tel: +372 6100 565</span></p></cell><cell><p><span style="bold">Norge</span></p><p><span>Actavis Norway AS Tlf: +47 815 22 099</span></p></cell></row><row><cell><p><span style="bold">Ελλάδα</span></p><p><span>Specifar ABEE</span></p><p><span>Τηλ: +30 210 5401500</span></p></cell><cell><p><span style="bold">Österreich</span></p><p><span>Actavis GmbH</span></p><p><span>Tel: +43 (0)662 435 235 00</span></p></cell></row><row><cell><p><span style="bold">España</span></p><p><span>Actavis Spain, S.A. Tfno.: +34 91 630 86 45</span></p></cell><cell><p><span style="bold">Polska</span></p><p><span>Actavis Export Int. Ltd., Malta.</span></p><p><span>Kontakt w Polsce:</span></p><p><span>Tel: (+48 22) 512 29 00</span></p></cell></row><row><cell><p><span style="bold">France</span></p><p><span>Actavis France</span></p><p><span>Tél: +33 4 72 72 60 72</span></p></cell><cell><p><span style="bold">Portugal</span></p><p><span>Aurovitas, Unipessoal, Lda Tel: +351 214 185 104</span></p></cell></row><row><cell><p><span style="bold">Hrvatska</span></p><p><span>Agmar d.o.o.</span></p><p><span>Tel: +385(1)6610-333</span></p></cell><cell><p><span style="bold">România</span></p><p><span>Actavis SRL</span></p><p><span>Tel: +40 21 318 17 77</span></p></cell></row><row><cell><p><span style="bold">Ireland</span></p><p><span>Actavis Ireland Limited Tel: +353 (0)21 4619040</span></p></cell><cell><p><span style="bold">Slovenija</span></p><p><span>Apta Medica Internacional d.o.o. Tel: +386 51 615 015</span></p></cell></row><row><cell><p><span style="bold">Ísland</span></p><p><span>Actavis Group PTC ehf. Sími: +354 550 3300</span></p></cell><cell><p><span style="bold">Slovenská republika</span></p><p><span>Actavis s.r.o.</span></p><p><span>Tel: +421 2 3255 3800</span></p></cell></row><row><cell><p><span style="bold">Italia</span></p><p><span>Aurobindo Pharma (Italia) s.r.l. Tel: +39 0296392601</span></p></cell><cell><p><span style="bold">Suomi/Finland</span></p><p><span>Actavis Oy</span></p><p><span>Puh/Tel: +358 (0)9 348 233</span></p></cell></row><row><cell><p><span style="bold">Κύπρος</span></p><p><span>A. Potamitis Medicare Ltd Τηλ: +357 22583333</span></p></cell><cell><p><span style="bold">Sverige</span></p><p><span>Actavis AB</span></p><p><span>Tel: +46 8 13 63 70</span></p></cell></row></table><anchors id="page3"></anchors><p><span style="bold">Latvija</span></p><p><span>Actavis Baltics pārstāvniecība Latvijā Tel: +371 67067873</span></p><p><span style="bold">This leaflet was last revised in</span><span> {MM/YYYY}.</span></p><p><span style="bold">United Kingdom</span></p><p><span>Actavis UK Limited Tel: +44 1271 385257</span></p><p><span>Detailed information on this medicine is available on the European Medicines Agency web site:</span><span style="underline"><a href="http://www.ema.europa.eu"> http://www.ema.europa.eu</a></span><span>/.</span></p></root>